Clinical trials
Completed Angina, Stable trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CID - Carbostent & Implantable Devices | 3 |
| Shiraz University of Medical Sciences | 3 |
| An-Najah National University | 2 |
| Imperial College London | 2 |
| Laval University | 2 |
| Maastricht University Medical Center | 2 |
| Mayo Clinic | 2 |
| Norwegian University of Science and Technology | 2 |
| Papworth Hospital NHS Foundation Trust | 2 |
| Roxane Laboratories | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina, Stable | 67 |
| Coronary Artery Disease | 23 |
| Angina, Unstable | 21 |
| Acute Coronary Syndrome | 9 |
| Angina Pectoris | 9 |
| Myocardial Infarction | 9 |
| Myocardial Ischemia | 6 |
| Non-ST Elevated Myocardial Infarction | 6 |
| Atherosclerosis | 5 |
| Coronary Disease | 5 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.